Thomas Bols

Thomas Bols

Head of Government Affairs and Patient Advocacy, EMEA & APAC at PTC Therapeutics, Inc.

Member of the Board of EuropaBio

Thomas Bols is PTC Therapeutics’ Head of Government Affairs and Patient Engagement, EMEA & APAC.

Thomas joined PTC in March 2020, continuing his career in the biopharmaceutical industry, having held positions for Amgen, Merck, Biogen and, most recently, at the global association, DIA.  He has worked in the interconnected areas of market access, government affairs, public affairs, health policy, corporate communications, and patient advocacy. In each role, Thomas has spearheaded initiatives that are crucial to bringing much-needed medicines to patients. Throughout his career, Thomas has advised and represented companies, as well as industry federations in engagements with policy makers, patient representatives, media, regulators, payers, and other national and European health policy platforms.

Thomas held board positions at several European associations, such as Europabio and EUCOPE, chaired a variety of working groups related to regulatory and access issues within EFPIA, and has been a member of the European Commission High Level Pharmaceutical Forum (2005-2008) and its Process on Corporate Responsibility in the Field of Pharmaceuticals (2010-2012).

Advertizing
Advertizing

Other speakers in 2022

Gregorio Iraola

Uruguay

Gregorio Iraola, PhD

Group Leader (G4 Program), Institut Pasteur de Montevideo
Co-founder, Kinzbio
Carmen Raal

Estonia

Carmen Raal

Digital Transformation Adviser
e-Estonia
Sir Andrew Dillon

United Kingdom

Sir Andrew Dillon

Founding Chief Executive of NICE, the National Institute for Health and Care Excellence (1999 – 2020)
Visiting professor at the Institute of Global Health Innovation, Imperial College, London Independent advisor
Sandrine Lavalle

Luxembourg

Sandrine Lavallé

Engagement and Communication Officer
Luxembourg Institute of Health (LIH)
Skip to content